Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Newly physician diagnosed and all participants with well controlled systemic arterial hypertension receiving antihypertensive drug therapy. 2)Systemic Hypertension Prehypertension (systolic blood pressure > 130 mm Hg - 80 mm Hg - 89 mm Hg)12 Stage 1 (systolic blood pressure >140 - 159 mm Hg or diastolic blood pressure > 90 - 99 mm Hg)
Exclusion criteria
Exclusion criteria: 1)Stage 2 hypertension â?? systolic blood pressure >160 mm Hg and diastolic blood pressure >100mm Hg12 2)Accelerated hypertension/Hypertensive crisis 3)Any change of antihypertensive drug regime (dosage) during the study period. 4)Current h/o Cardiac Arrhythmias (on external or internal pacing devices, Implanted Cardioverter defibrillator (ICD)) 5)Pregnancy and Lactation 6)Known h/o valvular heart disease (aortic, mitral, tricuspid, pulmonic) 7)Known h/o malignancy â?? on previous or current chemotherapy, radiation therapy 8)Known c/o acute renal insufficiency 9)Known h/o neurological disease 10)Known h/o arterial aneurysms 11)Known case of musculoskeletal trauma with disability 12)Known h/o of vertigo 13)Inability to comprehend and follow instructions for the Mat Pilates exercises
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1)Resting arterial systolic and diastolic blood pressure (mm Hg) 2)Central Systolic blood pressure (mm Hg) 3)Central Pulse pressure (mm Hg) 4)Mean Arterial pressure (mm Hg) Timepoint: Baseline - Day 0 (Week 1) Post - Day 90 (Week 12) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)World Health Organization BREF Health Related Quality of Life (WHO BREF questionnaire scores) 2)Left ventricular ejection fraction (%) 3)Left ventricular end diastolic volume (ml) Timepoint: Baseline - Day 0 (Week 1) Post - Day 90 (Week 12) | — |
Countries
India
Contacts
Kasturba Medical College, Manipal Academy of Higher Education